Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients
European Journal of Cancer · 2023-08 · 189 · 112933
DOI: 10.1016/j.ejca.2023.05.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023-08. Verfasst von Mara Persano und 59 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, University and University Hospital of Cagliari, Italy. Electronic address: marapersano@alice.it. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, University and University Hospital of Cagliari, Italy. Electronic address: marapersano@alice.it.
- Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
- Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.
- Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
- Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Zitieren
APA
Persano, M., Rimini, M., Tada, T., Suda, G., Shimose, S., Kudo, M., Cheon, J., Finkelmeier, F., Lim, H. Y., Presa, J., Masi, G., Yoo, C., Lonardi, S., Tovoli, F., Kumada, T., Sakamoto, N., Iwamoto, H., Aoki, T., Chon, H. J., …, & Tsutsui, A. (2023). Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients. European Journal of Cancer, 189, 112933. https://doi.org/10.1016/j.ejca.2023.05.021
Vancouver
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, et al. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients. European Journal of Cancer. 2023;189:112933. doi:10.1016/j.ejca.2023.05.021
BibTeX
@article{Persano2023,
author = {Persano, Mara and Rimini, Margherita and Tada, Toshifumi and Suda, Goki and Shimose, Shigeo and Kudo, Masatoshi and Cheon, Jaekyung and Finkelmeier, Fabian and Lim, Ho Yeong and Presa, José and Masi, Gianluca and Yoo, Changhoon and Lonardi, Sara and Tovoli, Francesco and Kumada, Takashi and Sakamoto, Naoya and Iwamoto, Hideki and Aoki, Tomoko and Chon, Hong Jae and Himmelsbach, Vera and Niizeki, Takashi and Montes, Margarida and Vivaldi, Caterina and Soldà, Caterina and Stefanini, Bernardo and Hiraoka, Atsushi and Sho, Takuya and Nishida, Naoshi and Steup, Christoph and Iavarone, Massimo and Di Costanzo, Giovanni and Marra, Fabio and Tamburini, Emiliano and Cabibbo, Giuseppe and Foschi, Francesco Giuseppe and Silletta, Marianna and Hirooka, Masashi and Kariyama, Kazuya and Tani, Joji and Atsukawa, Masanori and Takaguchi, Koichi and Itobayashi, Ei and Fukunishi, Shinya and Tsuji, Kunihiko and Ishikawa, Toru and Tajiri, Kazuto and Ochi, Hironori and Yasuda, Satoshi and Toyoda, Hidenori and Ogawa, Chikara and Nishimura, Takashi and Hatanaka, Takeshi and Kakizaki, Satoru and Shimada, Noritomo and Kawata, Kazuhito and Tada, Fujimasa and Ohama, Hideko and Nouso, Kazuhiro and Morishita, Asahiro and Tsutsui, Akemi},
title = {Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients},
journal = {European Journal of Cancer},
year = {2023},
volume = {189},
pages = {112933},
doi = {10.1016/j.ejca.2023.05.021}
}
EUVIMED